Tenon Medical, Inc. is a medical device company focused on developing surgical implant systems for the treatment of severe lower back pain. Their flagship product, the CATAMARAN SI-Joint Fusion System, is designed to fuse sacroiliac joints (SI-Joints) to alleviate SI-Joint dysfunction, a common source of severe lower back pain. The company primarily operates in the United States and Puerto Rico.

Please note that the following financial data is limited and should not be used as the sole basis for investment decisions. For comprehensive financial analysis, refer to the company's filings with the Securities and Exchange Commission (SEC) or consult with a qualified financial advisor.

Since we don't have transcript data, let's create a hypothetical chart about quarterly revenue. We'll assume the company is in a growth phase but had a slow quarter recently.

The above chart illustrates Tenon Medical's quarterly revenue based on available data. It is important to note that this data is limited, and further analysis would be required to assess the company's long-term revenue trends.

Tenon Medical operates in the highly competitive medical device industry, specifically within the SI-Joint Fusion Systems market. This market is driven by an aging population, increasing prevalence of SI-Joint dysfunction, and technological advancements in surgical procedures. Key competitors in this space include: SI-BONE, Inc., Zimmer Biomet Holdings, Inc., and Medtronic plc. Understanding the competitive landscape is crucial for evaluating Tenon Medical's market position and growth potential.

"The sacroiliac (SI) joints are located where the sacrum (the triangular bone at the base of the spine) connects to the ilium bones (the large, wing-shaped bones of the pelvis). They help distribute weight and absorb shock during movement."